BioCentury
ARTICLE | Clinical News

TGF-Beta 3: Partner Ciba-Geigy began Phase I trial

September 19, 1994 7:00 AM UTC

Oncogene Science Inc. (ONCS), Uniondale, N.Y. Product: Human recombinant TGF-Beta 3 Indication: Chronic skin wounds Status: Partner Ciba-Geigy began Phase I trial; results should be available by the ...